Volume 16, Number 10—October 2010
Dispatch
Toxoplasma gondii Oocyst–specific Antibodies and Source of Infection
Figure
![Detection of Toxoplasma gondii in 494 low-income pregnant women from Valdivia Province, Chile. *<15%, indicates acute infection; †15%–30%, indicates possible infection within <6 mo (4 samples from recently infected women were not tested for SSP antibodies); ‡>30%, excludes recent (within 3 mo) infection (9 samples from women with chronic infection were not tested for SSP antibodies). –, negative; +, positive; Ig, immunoglobulin; SSP, sporozoite-specific protein antibodies.](/eid/images/09-1674-F1.gif)
Figure. Detection of Toxoplasma gondii in 494 low-income pregnant women from Valdivia Province, Chile. *<15%, indicates acute infection; †15%–30%, indicates possible infection within <6 mo (4 samples from recently infected women were not tested for SSP antibodies); ‡>30%, excludes recent (within 3 mo) infection (9 samples from women with chronic infection were not tested for SSP antibodies). –, negative; +, positive; Ig, immunoglobulin; SSP, sporozoite-specific protein antibodies.
Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.